Search alternatives:
patients decrease » point decrease (Expand Search), treatments decreased (Expand Search)
marked decrease » marked increase (Expand Search)
patients decrease » point decrease (Expand Search), treatments decreased (Expand Search)
marked decrease » marked increase (Expand Search)
-
1
-
2
Table 3_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx
Published 2025“…Compared with patients with PNI ≥ 43, patients with PNI < 43 had a 118% increased risk of 30-day mortality (HR = 2.18, 95% CI = 1.28–3.81, p = 0.005) and a 96% increased risk of 90-day mortality (HR = 1.96, 95% CI = 1.20–3.19, p = 0.008). …”
-
3
-
4
-
5
-
6
Table 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx
Published 2025“…Compared with patients with PNI ≥ 43, patients with PNI < 43 had a 118% increased risk of 30-day mortality (HR = 2.18, 95% CI = 1.28–3.81, p = 0.005) and a 96% increased risk of 90-day mortality (HR = 1.96, 95% CI = 1.20–3.19, p = 0.008). …”
-
7
Table 2_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx
Published 2025“…Compared with patients with PNI ≥ 43, patients with PNI < 43 had a 118% increased risk of 30-day mortality (HR = 2.18, 95% CI = 1.28–3.81, p = 0.005) and a 96% increased risk of 90-day mortality (HR = 1.96, 95% CI = 1.20–3.19, p = 0.008). …”
-
8
Table 5_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx
Published 2025“…Compared with patients with PNI ≥ 43, patients with PNI < 43 had a 118% increased risk of 30-day mortality (HR = 2.18, 95% CI = 1.28–3.81, p = 0.005) and a 96% increased risk of 90-day mortality (HR = 1.96, 95% CI = 1.20–3.19, p = 0.008). …”
-
9
Table 4_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx
Published 2025“…Compared with patients with PNI ≥ 43, patients with PNI < 43 had a 118% increased risk of 30-day mortality (HR = 2.18, 95% CI = 1.28–3.81, p = 0.005) and a 96% increased risk of 90-day mortality (HR = 1.96, 95% CI = 1.20–3.19, p = 0.008). …”
-
10
Image 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.tif
Published 2025“…Compared with patients with PNI ≥ 43, patients with PNI < 43 had a 118% increased risk of 30-day mortality (HR = 2.18, 95% CI = 1.28–3.81, p = 0.005) and a 96% increased risk of 90-day mortality (HR = 1.96, 95% CI = 1.20–3.19, p = 0.008). …”
-
11
-
12
-
13
Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA....
Published 2025“…Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. …”
-
14
-
15
-
16
Patient characteristics.
Published 2025“…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”
-
17
-
18
-
19
The structures of T3 and Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
20